Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal
Completed · Early Phase 1
Conditions studied: Drug Overdose, Opioid Withdrawal, Opioid-use Disorder
In brief
The investigators are trying to determine whether they can effectively treat patients suffering from acute opioid withdrawal in the Emergency Department at Virginia Commonwealth University Health System (VCUHS) and subsequently transfer them to an outpatient addiction clinic within the existing infrastructure. This will be a descriptive investigation of the process to reveal areas of success and opportunities for improvement in order to determine feasibility of the study procedures in preparation for a larger clinical investigation.
Key facts
- Study ID
- NCT03489161
- Run by
- Virginia Commonwealth University
- People needed
- 3
- Starts
- 2018-08-01
- Expected to finish
- 2018-08-28
- Last updated by the study team
- 2018-12-13
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Opioid overdose only, of any formulation or route, with complete reversal of toxicity after naloxone by any route.
- RR ≥ 12
- Pulse oximetry > 95%
- GCS 15
- Clinical Opioid Withdrawal Scale (COWS) score ≥ 8
You may not qualify if…
- Pregnancy
- Prisoner
- Incomplete reversal of toxicity related to metrics above
- Police custody
- Known allergy to buprenorphine
- Emergent psychiatric condition including active suicidality that requires admission
- Emergent medical condition that requires admission
Where it is running
- Virginia Commonwealth University — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.